Seeing Is Believing
Currently out of the existing stock ratings of Michael Higgins, 50 are a BUY (89.29%), 6 are a HOLD (10.71%).
Analyst Michael Higgins works at LADENBURG with a stock forecast success ratio of 44.38% fulfilled within 176.94 days on average.
Michael Higgins’s has documented 121 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRDN, Viridian Therapeutics at 09-May-2024.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 5/14/2020. The price target of $50 was fulfilled within 4 days with a profit of $11.7 (30.55%) receiving and performance score of 76.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
18
$13.47 (297.35%)
1 months 9 days ago
0/4 (0%)
$13.42 (293.01%)
Buy
4 months 28 days ago
1/1 (100%)
$-45.93 (-79.19%)
189
Buy
19
$14.47 (319.43%)
31
11 months 9 days ago
0/3 (0%)
$12.8 (206.45%)
Which stock is Michael Higgins is most bullish on?
Which stock is Michael Higgins is most reserved on?
What Year was the first public recommendation made by Michael Higgins?